CClinicalTrials.gg
Not yet recruitingNCT07727772Updated Jul 27, 2026

Vascular Aging and Acute Kidney Injury After Cardiac Surgery

An observational study in Acute Kidney Injury Cardiac Surgery, Postoperative Complications and Vascular Aging, sponsored by Nanjing First Hospital, Nanjing Medical University. Not yet recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-27.

Sponsored by Nanjing First Hospital, Nanjing Medical University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
472
Ages
18 Years and older
Sex
All
01

Study summary

This prospective observational cohort study will enroll adult patients undergoing cardiac surgery at Nanjing First Hospital, Nanjing Medical University. The study will evaluate multidimensional vascular aging markers before surgery and assess their association with postoperative acute kidney injury within 7 days after surgery. No intervention will be assigned by the study protocol, and all perioperative management will follow routine clinical practice.

Read the detailed description

Acute kidney injury is a common postoperative complication after cardiac surgery and is associated with adverse short-term and long-term outcomes. Vascular aging may reflect systemic vascular dysfunction, impaired vascular compliance, endothelial dysfunction, and reduced renal perfusion reserve, which may increase susceptibility to postoperative acute kidney injury.

This prospective observational cohort study will include adult patients scheduled to undergo cardiac surgery at Nanjing First Hospital, Nanjing Medical University. Perioperative vascular aging-related indicators will be collected according to the study protocol. These indicators may include noninvasive vascular assessments, hemodynamic measurements, and relevant clinical and laboratory variables. Postoperative renal function will be monitored after surgery, and acute kidney injury will be assessed within 7 days after surgery according to predefined diagnostic criteria.

The primary objective is to investigate the association between multidimensional vascular aging markers and the occurrence and severity of postoperative acute kidney injury. Secondary analyses may evaluate the relationships between vascular aging burden and postoperative clinical outcomes, including intensive care unit stay, hospital stay, and other postoperative complications when available. This is an observational study, and no treatment, surgical procedure, or perioperative management strategy will be assigned by the study protocol.

02

Conditions studied

  • Acute Kidney Injury Cardiac Surgery
  • Postoperative Complications
  • Vascular Aging

Keywords

  • vascular aging
  • acute kidney injury
  • postoperative complications
03

In context

Postoperative Complications

1,233 studies on the registry are indexed under Postoperative Complications; 292 are open to participants now.

This study's planned enrollment of 472 is above the median of 254 across 519 observational studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

Nanjing First Hospital, Nanjing Medical University is the lead sponsor of 213 studies on the registry; 106 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of adult patients undergoing cardiac surgery at Nanjing First Hospital, Nanjing Medical University. Eligible patients will receive perioperative vascular aging assessment and postoperative renal function monitoring according to the study protocol. Participants will be followed for postoperative acute kidney injury within 7 days after surgery.

Inclusion criteria

  • Adult patients aged 18 years or older.
  • Patients scheduled to undergo cardiac surgery at Nanjing First Hospital, Nanjing Medical University.
  • Patients who are able to provide written informed consent.
  • Patients who are expected to undergo perioperative vascular aging assessment and postoperative renal function monitoring according to the study protocol.

Exclusion criteria

Exclusion Criteria:

  • Patients younger than 18 years.
  • Patients with preoperative end-stage renal disease or maintenance dialysis.
  • Patients who are unable to complete the study-specified vascular aging assessment.
  • Patients who decline participation or withdraw informed consent.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
472 participants (estimated)
Patient registry
No

Groups and cohorts

  • Cardiac Surgery Cohort

    Adult patients undergoing cardiac surgery at Nanjing First Hospital who will receive perioperative vascular aging assessment and postoperative renal function monitoring according to the study protocol. No treatment or perioperative management strategy will be assigned by the study protocol.

    Other: Multidimensional Vascular Aging Assessment

Interventions

  • OtherMultidimensional Vascular Aging Assessment

    Perioperative assessment of vascular aging-related indicators, including noninvasive vascular assessments, hemodynamic measurements, and relevant clinical and laboratory variables. The assessment is observational and will not determine the treatment, surgical procedure, or perioperative management assigned to participants.

06

What researchers measure

Primary outcomes

  1. Incidence of Postoperative Acute Kidney Injury Within 7 Days After Surgery

    Postoperative acute kidney injury will be assessed within 7 days after surgery according to predefined diagnostic criteria based on postoperative renal function changes. The outcome will be recorded as the occurrence of acute kidney injury during the postoperative 7-day period.

    Time frame: From the date of surgery to postoperative day 7

Secondary outcomes

  1. Severity of Postoperative Acute Kidney Injury

    The severity of postoperative acute kidney injury will be classified according to predefined staging criteria during the postoperative 7-day period.

    Time frame: From the date of surgery to postoperative day 7

07

Study locations

1 site
  • Nanjing First Hospital, Nanjing Medical University
    Nanjing, Jiangsu 210006, China
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared because the study involves clinical data from hospitalized patients and data sharing is restricted by institutional policies and participant privacy protection requirements. De-identified aggregate results may be made available in publications.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07727772
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Responsible party
Sponsor
First posted
Jul 27, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Feb 21, 2027 (estimated)
Completion
Dec 28, 2027 (estimated)
Last update
Jul 27, 2026

Study contacts

F Hu
Contact
feifanhu0722@foxmail.com
+8615162614385

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion